Prevalence and Development of Liver Dysfunction in Hematopoietic Stem Cell Transplant | MicrobiomeTrials← Back to trialsNCT05722210
Prevalence and Development of Liver Dysfunction in Hematopoietic Stem Cell Transplant
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-07-30Est. Completion: 2031-06-30
Enrollment target: 500 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
B-cell Acute Lymphoblastic LeukemiaDiffuse Large B-cell LymphomaBurkitt LymphomaNeuroblastomaEwing Sarcoma
Substudy 01A is part of a platform study. The purpose of this study is to assess the efficacy and safety of zilovertamab…
Los Angeles, United StatesEst. completion Mar 31, 2029
LeukemiaLymphomaMultiple MyelomaMyelodysplastic Syndromes (MDS)Myeloproliferative Neoplasm
Cancer and treatment-related cognitive changes, such as thinking or remembering, hinder resumption of normal routine and…
Omaha, United StatesEst. completion Jul 2027
B-AllAcute Lymphoblastic Leukemia
Background:
Chimeric antigen receptor T-cell (CART) therapy is a form of immunotherapy which can be used to treat peopl…
Los Angeles, United StatesEst. completion Dec 31, 2026